Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IGFBP6 Antibodies:
anti-Mouse (Murine) IGFBP6 Antibodies:
anti-Rat (Rattus) IGFBP6 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IGFBP6 Primary Antibody for FACS, IHC (p) - ABIN390729
Guey, García-Closas, Murta-Nascimento, Lloreta, Palencia, Kogevinas, Rothman, Vellalta, Calle, Marenne, Tardón, Carrato, García-Closas, Serra, Silverman, Chanock, Real, Malats: Genetic susceptibility to distinct bladder cancer subphenotypes. in European urology 2010
Human Polyclonal IGFBP6 Primary Antibody for IF (p), IHC (p) - ABIN753298
Yuan, Han, Cong, Ge, Ma, Dai, Li, Bi: Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity. in International journal of nanomedicine 2014
Human Polyclonal IGFBP6 Primary Antibody for ELISA, WB - ABIN409084
Cheung, Vesey, Cotterill, Douglas, Gobe, Nicol, Johnson: Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas. in International journal of urology : official journal of the Japanese Urological Association 2005
We found that IGFBP6 and SATB2 (show SATB2 Antibodies) were significantly down-regulated in HIV-infected CEM*174 cells and 3 different cohorts of HIV/AIDS patients while their promoters were predominantly hyper-methylated compared with normal controls.
IGFBP6 attenuation in ACTH (show POMC Antibodies)-secreting pituitary adenomas is associated with tumor growth, through activation of PI3K (show PIK3CA Antibodies)-AKT (show AKT1 Antibodies)-mTOR (show FRAP1 Antibodies) pathway
CCL-18 (show CCL18 Antibodies) and IGFBP-6 were identified as new potential serum biomarkers for prostate cancer.
When the concentrations of IGFBP-6 or KNG1 (show KNG1 Antibodies) were greater than 98.5 pg/ml or 88.5 ng/ml, respectively, they predicted the proliferative vitreoretinopathy prognosis.
Our results indicate that IGF2 and IGFBP6 appear to govern various regulatory feedback mechanisms in periodontal ligament cells
Data indicate that IGFBP-6 binds to prohibitin-2 (show PHB2 Antibodies) on the cell membrane, and knockdown of the latter abrogates IGFBP-6-induced migration.
This is the first report to implicate IGFBP-6 as a suppressor of cellular proliferation and IGF-II as an inducer of cellular contractility in this connective tissue disease.
Review of the IGF system in physiology and disease with a focus on the regulation and actions of IGFBP-6, and its potential roles in cancer cells.
These results suggest that the expression of IGFBP-6 in vascular endothelial cells is up-regulated by hypoxia and IGFBP-6 inhibits angiogenesis in vitro and in vivo
IGFBP-6 acts as a inhibitory mediator of thyroid hormone (show PTH Antibodies) effects in osteoblast differentiation
Genome-wide methylation analysis showed that two genes with hypomethylated promoters, Igfbp6 and Foxs1, are upregulated in GDX (show UBL4A Antibodies)-induced adrenocortical neoplasms.
Igfbp-6 is a target of sonic hedgehog (show SHH Antibodies) signaling in the urogenital sinus
These results reveal a novel function for MMP-9 (show MMP9 Antibodies) and -12 in developmental myelination likely through regulating IGF-1 (show IGF1 Antibodies) bioavailability.
Report multiple post-translational modifications of mouse insulin-like growth factor binding protein-6 expressed in epithelial Madin-Darby canine kidney cells.
high-affinity IGF binding ptotein with substantially greater affinity for insulin-like growth factor-II (IGF-II) than IGF-I
insulin-like growth factor binding protein 6
, IGF binding protein 6
, IGF-binding protein 6
, insulin-like growth factor-binding protein 6
, INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6 PRECURSOR (IGFBP-6) (IBP-6) (IGF-BINDING PROTEIN 6)